======= BRPF1 ======= == Gene Information == * **Official Symbol**: BRPF1 * **Official Name**: bromodomain and PHD finger containing 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=7862|7862]] * **UniProt**: [[https://www.uniprot.org/uniprot/P55201|P55201]] * **Interactions**: [[https://thebiogrid.org/search.php?search=BRPF1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20BRPF1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/602410|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a bromodomain, PHD finger and chromo/Tudor-related Pro-Trp-Trp-Pro (PWWP) domain containing protein. The encoded protein is a component of the MOZ/MORF histone acetyltransferase complexes which function as a transcriptional regulators. This protein binds to the catalytic MYST domains of the MOZ and MORF proteins and may play a role in stimulating acetyltransferase and transcriptional activity of the complex. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]. * **UniProt Summary**: Component of the MOZ/MORF complex which has a histone H3 acetyltransferase activity (PubMed:16387653, PubMed:27939640). Preferentially mediates histone H3-K23 acetylation (PubMed:27939640). Positively regulates the transcription of RUNX1 and RUNX2 (PubMed:18794358). {ECO:0000269|PubMed:16387653, ECO:0000269|PubMed:18794358, ECO:0000269|PubMed:27939640}. |PHD| |PWWP| |Bromodomain| |EPL1| |histone H3-K23 acetylation| |histone acetyltransferase activity (H3-K23 specific)| |MOZ/MORF histone acetyltransferase complex| |histone H3 acetylation| |histone acetylation| |internal peptidyl-lysine acetylation| |peptidyl-lysine acetylation| |internal protein amino acid acetylation| |protein acetylation| |regulation of signal transduction by p53 class mediator| |protein acylation| |peptidyl-lysine modification| |histone modification| |covalent chromatin modification| |chromatin organization| |peptidyl-amino acid modification| |chromosome organization| |DNA binding| |positive regulation of transcription, DNA-templated| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |positive regulation of RNA metabolic process| |regulation of intracellular signal transduction| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp449|Arsenic trioxide 60μM R08 exp449]]|-2.2| |[[:results:exp434|Vemurafenib 6.6μM R08 exp434]]|-2.13| |[[:results:exp365|I-BRD9 4μM R07 exp365]]|-2.11| |[[:results:exp510|Nicotine 3000μM R08 exp510]]|-2.01| |[[:results:exp216|Erlotinib 10μM R05 exp216]]|-1.96| |[[:results:exp162|BI-D1870 2μM R04 exp162]]|-1.87| |[[:results:exp148|SB202190 10μM R03 exp148]]|-1.84| |[[:results:exp30|Rapamycin 10μM R00 exp30]]|-1.83| |[[:results:exp115|A-366 10μM R03 exp115]]|-1.77| |[[:results:exp95|BI-2536 0.0042μM R03 exp95]]|1.7| |[[:results:exp517|Quercetin 20μM R08 exp517]]|1.7| |[[:results:exp226|Cerivastatin 0.15μM R05 exp226]]|1.74| |[[:results:exp59|UMK57 1μM R01 exp59]]|1.89| |[[:results:exp357|Dorsomorphin 5μM R07 exp357]]|1.91| |[[:results:exp214|2-Deoxy-D-glucose 800μM R05 exp214]]|2.13| |[[:results:exp80|RO-3307 4.7μM R02 exp80]]|2.17| |[[:results:exp499|LY2090314 0.003μM R08 exp499]]|2.42| |[[:results:exp500|LY2090314 0.003μM R08 exp500 no dilution day6]]|2.69| |[[:results:exp175|3-Bromopyruvate 7μM R04 exp175]]|3.66| |[[:results:exp106|UM131593 0.2μM R03 exp106]]|3.86| ^Gene^Correlation^ |[[:human genes:z:znf592|ZNF592]]|0.574| |[[:human genes:i:id3|ID3]]|0.557| |[[:human genes:m:med13l|MED13L]]|0.55| |[[:human genes:n:nsd1|NSD1]]|0.548| |[[:human genes:m:mllt1|MLLT1]]|0.528| |[[:human genes:t:trim28|TRIM28]]|0.519| |[[:human genes:t:taf5l|TAF5L]]|0.515| |[[:human genes:c:ccdc101|CCDC101]]|0.495| |[[:human genes:k:kat6a|KAT6A]]|0.492| |[[:human genes:m:med23|MED23]]|0.491| |[[:human genes:w:wdr24|WDR24]]|0.491| |[[:human genes:t:taf6l|TAF6L]]|0.48| |[[:human genes:t:tada1|TADA1]]|0.475| |[[:human genes:m:med13|MED13]]|0.475| |[[:human genes:s:ssbp2|SSBP2]]|0.475| |[[:human genes:t:tada3|TADA3]]|0.473| |[[:human genes:k:kat2a|KAT2A]]|0.462| |[[:human genes:s:supt7l|SUPT7L]]|0.461| |[[:human genes:z:zmiz1|ZMIZ1]]|0.46| |[[:human genes:s:setdb1|SETDB1]]|0.458| |[[:human genes:z:zmynd8|ZMYND8]]|0.452| |[[:human genes:t:tle4|TLE4]]|0.451| |[[:human genes:b:bap1|BAP1]]|0.45| |[[:human genes:m:meaf6|MEAF6]]|0.449| |[[:human genes:t:tada2b|TADA2B]]|0.448| |[[:human genes:c:celf1|CELF1]]|0.448| |[[:human genes:d:dohh|DOHH]]|0.445| |[[:human genes:l:ldb1|LDB1]]|0.442| |[[:human genes:c:ctdspl2|CTDSPL2]]|0.439| |[[:human genes:i:ing5|ING5]]|0.434| |[[:human genes:v:vcpip1|VCPIP1]]|0.433| |[[:human genes:d:dcaf7|DCAF7]]|0.433| |[[:human genes:e:erg|ERG]]|0.432| |[[:human genes:s:scaf8|SCAF8]]|0.431| |[[:human genes:m:mtor|MTOR]]|0.43| |[[:human genes:r:rptor|RPTOR]]|0.426| |[[:human genes:u:usp22|USP22]]|0.425| |[[:human genes:h:hhex|HHEX]]|0.424| |[[:human genes:i:irf2bp2|IRF2BP2]]|0.423| |[[:human genes:a:atf7ip|ATF7IP]]|0.421| |[[:human genes:a:ahcyl1|AHCYL1]]|0.418| |[[:human genes:r:runx1|RUNX1]]|0.416| |[[:human genes:s:spag7|SPAG7]]|0.416| |[[:human genes:m:maml1|MAML1]]|0.416| |[[:human genes:b:bptf|BPTF]]|0.413| |[[:human genes:p:papola|PAPOLA]]|0.412| |[[:human genes:o:otud5|OTUD5]]|0.411| |[[:human genes:m:mef2c|MEF2C]]|0.409| |[[:human genes:f:fli1|FLI1]]|0.408| |[[:human genes:m:med10|MED10]]|0.406| |[[:human genes:a:azin1|AZIN1]]|0.405| |[[:human genes:u:ube2l3|UBE2L3]]|0.404| |[[:human genes:d:ddx5|DDX5]]|0.401| |[[:human genes:u:ube2g1|UBE2G1]]|0.401| |[[:human genes:z:znf608|ZNF608]]|0.4| Global Fraction of Cell Lines Where Essential: 5/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|1/28| |bone|0/25| |breast|1/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|1/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|1/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 1044 * **Expression level (log2 read counts)**: 6.24 {{:chemogenomics:nalm6 dist.png?nolink |}}